From: TMD pain: the effect on health related quality of life and the influence of pain duration
 | Group | ||
---|---|---|---|
 | 1 | 2 | 3 |
Total | 15 | 16 | 64 |
Female/male | 1/14 | 3/13 | 1/63 |
Age (sd) | 37.6 (14.4) | 37.5 (14.1) | 41.6 (12.5) |
RDC/TMD diagnosis: | n | n | n |
Group I | 3 | 8 | 20 |
Group II | 0 | 0 | 3 |
Group III | 5 | 7 | 24 |
Group I + group II | 0 | 0 | 4 |
Group I + group III | 5 | 0 | 12 |
Group II + group III | 2 | 1 | 1 |
Analgesic usage | Â | Â | Â |
Paracetamol | 0 | 1 | 7 |
NSAID | 1 | 0 | 3 |
Tricyclic antidepressant | 1 | 5 | 6 |
Tricyclic antidepressant + paracetamol | 1 | 0 | 0 |
Tricyclic antidepressant + NSAID | 0 | 0 | 2 |
NSAID + opioid | 0 | 0 | 2 |
Other chronic pain condition | Â | Â | Â |
Rheumatoid arthritis | 0 | 2 | 1 |
Hernia | 0 | 0 | 1 |
Back pain | 0 | 0 | 1 |